AKT1 and neoplasm: These fusions further activate downstream effectors such as STAT3 and AKT. The FIG-ROS fusion driver gene has been shown to accelerate tumor growth in an orthotopic allograft mouse model, and that inactivation of the gene portends an antitumor effect [67].